English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

 
 
DownloadE-Mail

Released

Journal Article

Exome and whole genome sequencing in aging and longevity

MPS-Authors
/persons/resource/persons276058

Deelen,  J.
Deelen – Genetics and Biomarkers of Human Ageing, Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

van den Akker, E. B., Deelen, J., Slagboom, P. E., & Beekman, M. (2015). Exome and whole genome sequencing in aging and longevity. Adv Exp Med Biol, 847, 127-39. doi:10.1007/978-1-4939-2404-2_6.


Cite as: https://hdl.handle.net/21.11116/0000-000B-6BF5-9
Abstract
Calendar age is the major risk factor for common disease. It is therefore expected that understanding the aging process will eventually lead to promotion of better health conditions in elderly populations. Such insight may be obtained by identifying the genetic determinants of familial and exceptional longevity and age-related disease. Research of these determinants has been performed in candidate gene, genome-wide association and linkage studies. Because exploration of the common variation in the genome did not explain much of the variation in the rate of aging and longevity, researchers in the field have only recently started to investigate the contribution of rare genetic variants to these traits. The increased throughput and decreased costs of next generation sequencing (NGS) have resulted in a great deal of novel applications for sequencing sets of candidate genes, whole exomes, and whole genomes of individuals. Most of the successful NGS applications are as yet those focused on genetic syndromes and cancers for which causal mutations are readily being identified. In this chapter, we discuss the genetic and phenomic aspects of human aging research and the use of NGS data to identify genes relevant for age-related diseases and lifespan regulation, and to investigate the accumulation of somatic genetic variation during the course of life.